Sustainable Medicines Manufacturing Innovation: CR&D round 2
Sustainable Medicines Manufacturing Innovation: CR&D round 2 is a funding call from Innovate UK (UKRI) with DHSC that closes 02 December 2026. Funding: Up to £7 million total competition budget (per-project size: see the competition brief). Eligibility: Collaborations only; lead must be a UK-registered business, RTO, catapult, not-for-profit, public body or charity; consortium must include at least one UK SME claiming grant.
- Funder
- Innovate UK (UKRI) with DHSC
- Deadline
- 02 Dec 2026 (47 days)
- Status
- Open
- Amount
- Up to £7 million total competition budget (per-project size: see the competition brief)
- Region / eligibility
- UK
- Career stage
- established / PI
- Fields
- pharma process, crystallization, chemistry
- Reference
- —
- Official call
- Funder page (curated calendar) listing
Eligibility in plain language
Collaborations only; lead must be a UK-registered business, RTO, catapult, not-for-profit, public body or charity; consortium must include at least one UK SME claiming grant.
Who should apply
Medicinal chemists and pharma process / drug-development teams, crystal growth / crystallization researchers, synthetic, physical and analytical chemists — best fit for PIs and research groups able to join or build a multi-country consortium.
Summary from source
Grants for developing and adopting sustainable technologies for manufacturing medicines. UK collaborative grant for greener medicines manufacturing (e.g. cleaner crystallisation/isolation processes); needs a UK SME partner; closes 2 Dec 2026 11:00 UK time.